Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology

K. Temming; M. Lacombe; P. van der Hoeven; J. Pradash; T. Gonzalo; E.C.F. Dijkers; L. Orfi; G. Keri; K. Poelstra; G. Molema; R.J. Kok

Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology

K. Temming, M. Lacombe, P. van der Hoeven, J. Pradash, T. Gonzalo, E.C.F. Dijkers, L. Orfi, G. Keri, K. Poelstra, G. Molema, R.J. Kok

Dep Farmaceutische wetenschappen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1246-1255
Number of pages	10
Journal	Bioconjugate Chemistry
Volume	17
Publication status	Published - 2006

Keywords

Medical technology
Farmacie(FARM)
Biomedische technologie en medicijnen
Pharmacology

Access to Document

2006 34
Open Access (free)
Final published version, 459 KB

Cite this

Temming, K., Lacombe, M., van der Hoeven, P., Pradash, J., Gonzalo, T., Dijkers, E. C. F., Orfi, L., Keri, G., Poelstra, K., Molema, G., & Kok, R. J. (2006). Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology. Bioconjugate Chemistry, 17, 1246-1255.

@article{3c461cc9a0a44bc3b6b187608f6ce28c,

title = "Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology",

keywords = "Medical technology, Farmacie(FARM), Biomedische technologie en medicijnen, Pharmacology",

author = "K. Temming and M. Lacombe and {van der Hoeven}, P. and J. Pradash and T. Gonzalo and E.C.F. Dijkers and L. Orfi and G. Keri and K. Poelstra and G. Molema and R.J. Kok",

year = "2006",

language = "Undefined/Unknown",

volume = "17",

pages = "1246--1255",

journal = "Bioconjugate Chemistry",

issn = "1043-1802",

publisher = "American Chemical Society",

}

Temming, K, Lacombe, M, van der Hoeven, P, Pradash, J, Gonzalo, T, Dijkers, ECF, Orfi, L, Keri, G, Poelstra, K, Molema, G & Kok, RJ 2006, 'Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology', Bioconjugate Chemistry, vol. 17, pp. 1246-1255.

Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology. / Temming, K.; Lacombe, M.; van der Hoeven, P. et al.
In: Bioconjugate Chemistry, Vol. 17, 2006, p. 1246-1255.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology

AU - Temming, K.

AU - Lacombe, M.

AU - van der Hoeven, P.

AU - Pradash, J.

AU - Gonzalo, T.

AU - Dijkers, E.C.F.

AU - Orfi, L.

AU - Keri, G.

AU - Poelstra, K.

AU - Molema, G.

AU - Kok, R.J.

PY - 2006

Y1 - 2006

KW - Medical technology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Pharmacology

M3 - Article

SN - 1043-1802

VL - 17

SP - 1246

EP - 1255

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

ER -